Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4156)
All Articles published online
|
Jun 7, 2008 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chapman R, Cullen S. Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3350-3359 [PMID: 18528932 DOI: 10.3748/wjg.14.3350] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3350.htm |
| Number | Citing Articles |
| 1 |
Johannes Brühl, Moritz Schirren, Christel Wei, Christoph Antoni, Ulrich Böcker. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn’s disease. European Journal of Gastroenterology & Hepatology 2011; 23(10): 923 doi: 10.1097/MEG.0b013e3283499252
|
| 2 |
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
|
| 3 |
Christian Rupp, Konrad Alexander Bode, Fadi Chahoud, Andreas Wannhoff, Kilian Friedrich, Karl-Heinz Weiss, Peter Sauer, Wolfgang Stremmel, Daniel Nils Gotthardt. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/s12879-014-0562-8
|
| 4 |
Alberto Quaglia. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 423 doi: 10.1016/B978-0-323-42873-6.00027-5
|
| 5 |
Floris J. M. Roos, Marcel J. C. Bijvelds, Monique M. A. Verstegen, Henk P. Roest, Herold J. Metselaar, Wojciech G. Polak, Hugo R. de Jonge, Jan N. M. IJzermans, Luc J. W van der Laan. Impact of hypoxia and AMPK on CFTR-mediated bicarbonate secretion in human cholangiocyte organoids. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5): G741 doi: 10.1152/ajpgi.00389.2020
|
| 6 |
Kilian Friedrich, Mark Smit, Maik Brune, Thomas Giese, Christian Rupp, Andreas Wannhoff, Petra Kloeters, Yvonne Leopold, Gerald Ulrich Denk, Karl Heinz Weiss, Wolfgang Stremmel, Peter Sauer, Simon Hohenester, Peter Schirmacher, Peter Schemmer, Daniel Nils Gotthardt. CD14 is associated with biliary stricture formation. Hepatology 2016; 64(3): 843 doi: 10.1002/hep.28543
|
| 7 |
Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner. Liver Immunology. 2014; : 301 doi: 10.1007/978-3-319-02096-9_20
|
| 8 |
Verena Keitel, Maria Reich, Dieter Häussinger. TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?. Clinical Reviews in Allergy & Immunology 2015; 48(2-3): 218 doi: 10.1007/s12016-014-8443-x
|
| 9 |
Jörg Jahnel, Peter Fickert, Cord Langner, Christoph Högenauer, Dagmar Silbert, Judith Gumhold, Andrea Fuchsbichler, Michael Trauner. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver International 2009; 29(9): 1316 doi: 10.1111/j.1478-3231.2009.02044.x
|
| 10 |
Brian D. Juran, Elizabeth J. Atkinson, Erik M. Schlicht, Joseph J. Larson, David Ellinghaus, Andre Franke, Konstantinos N. Lazaridis. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver International 2011; 31(6): 785 doi: 10.1111/j.1478-3231.2010.02420.x
|
| 11 |
Klaudia Farkas, Ferenc Nagy, László Kovács, Éva Csajbók, Gabriella Kovács, Tibor Wittmann, Tamás Molnár. Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type III. Inflammatory Bowel Diseases 2010; 16(1): 10 doi: 10.1002/ibd.20913
|
| 12 |
Christopher L. Bowlus. Cutting Edge Issues in Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 2011; 41(2): 139 doi: 10.1007/s12016-010-8221-3
|
| 13 |
Ramon V. Cortez, Luana N. Moreira, Marina Padilha, Mariana D. Bibas, Ricardo K. Toma, Gilda Porta, Carla R. Taddei. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.598152
|
| 14 |
Natalia Szóstak, Marek Figlerowicz, Anna Philips. The emerging role of the gut mycobiome in liver diseases. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2211922
|
| 15 |
HANS‐UDO KASPER, DINA LIGUM, JELENA CUCUS, DIRK L. STIPPEL, HANS P. DIENES, UTA DREBBER. Liver distribution of γδ‐T‐cells in patients with chronic hepatitis of different etiology. APMIS 2009; 117(11): 779 doi: 10.1111/j.1600-0463.2009.02540.x
|
| 16 |
Lena Berglin, Annika Bergquist, Helene Johansson, Hans Glaumann, Carl Jorns, Sebastian Lunemann, Heiner Wedemeyer, Ewa C. Ellis, Niklas K. Björkström, Patricia Aspichueta. In Situ Characterization of Intrahepatic Non-Parenchymal Cells in PSC Reveals Phenotypic Patterns Associated with Disease Severity. PLoS ONE 2014; 9(8): e105375 doi: 10.1371/journal.pone.0105375
|
| 17 |
Alina Grama, Alexandra Mititelu, Claudia Sîrbe, Gabriel Benţa, Tudor Lucian Pop. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1206025
|
| 18 |
Jörg C. Hoffmann. Chronisch-entzündliche Darmerkrankungen. 2020; : 467 doi: 10.1007/978-3-662-59104-8_33
|
| 19 |
Riccardo Manfredi, Ilaria Baglio, Matteo De Iorio, Lucia Camera, Roberto Pozzi Mucelli. Magnetic Resonance Cholangiopancreatography (MRCP). 2013; : 77 doi: 10.1007/978-88-470-2844-9_4
|
| 20 |
Kidist K. Yimam, Christopher L. Bowlus. Diagnosis and classification of primary sclerosing cholangitis. Autoimmunity Reviews 2014; 13(4-5): 445 doi: 10.1016/j.autrev.2014.01.040
|
| 21 |
Driffa Moussata, Gilles Boschetti, Carmen Stefanescu, Stephane Nancey, Yoram Bouhnik, Bernard Flourie. Isolated ileitis associated with primary sclerosing cholangitis in three patients with Crohn’s disease. Scandinavian Journal of Gastroenterology 2016; 51(6): 727 doi: 10.3109/00365521.2015.1126634
|
| 22 |
Marcel Janse, Laetitia E. Lamberts, Lude Franke, Soumya Raychaudhuri, Eva Ellinghaus, Kirsten Muri Boberg, Espen Melum, Trine Folseraas, Erik Schrumpf, Annika Bergquist, Einar Björnsson, Jingyuan Fu, Harm Jan Westra, Harry J.M. Groen, Rudolf S.N. Fehrmann, Joanna Smolonska, Leonard H. van den Berg, Roel A. Ophoff, Robert J. Porte, Tobias J. Weismüller, Jochen Wedemeyer, Christoph Schramm, Martina Sterneck, Rainer Günther, Felix Braun, Severine Vermeire, Liesbet Henckaerts, Cisca Wijmenga, Cyriel Y. Ponsioen, Stefan Schreiber, Tom H. Karlsen, Andre Franke, Rinse K. Weersma.
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for
IL2, REL
, and
CARD9
. Hepatology 2011; 53(6): 1977 doi: 10.1002/hep.24307
|
| 23 |
Xinyang Li, Jun Shen, Zhihua Ran. Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease. Clinical Immunology 2017; 175: 115 doi: 10.1016/j.clim.2016.10.006
|
| 24 |
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseases. Seminars in Immunopathology 2014; 36(5): 553 doi: 10.1007/s00281-014-0439-3
|
| 25 |
Marion J. Pollheimer, Emina Halilbasic, Peter Fickert, Michael Trauner. Pathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 2011; 25(6): 727 doi: 10.1016/j.bpg.2011.10.009
|
| 26 |
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
|
| 27 |
Roberta Angioni, Bianca Calì, Vasanthy Vigneswara, Marika Crescenzi, Ana Merino, Ricardo Sánchez-Rodríguez, Cristina Liboni, Martin J. Hoogduijn, Philip Noel Newsome, Maurizio Muraca, Francesco Paolo Russo, Antonella Viola. Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. International Journal of Molecular Sciences 2020; 21(22): 8874 doi: 10.3390/ijms21228874
|
| 28 |
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
|
| 29 |
Beate E. Preuß, Christoph P. Berg, Christoph Werner, Sandra Plankenhorn, Nisar P. Malek, Reinhild Klein. Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0787-x
|
| 30 |
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
|
| 31 |
Dimitrios P. Bogdanos, Bin Gao, M. Eric Gershwin. Comprehensive Physiology. 2013; : 567 doi: 10.1002/cphy.c120011
|
| 32 |
|
| 33 |
Yu Gao, Jingwei Shao, Zhou Jiang, Jianzhong Chen, Songen Gu, Suhong Yu, Ke Zheng, Lee Jia. Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics. Drug Discovery Today 2014; 19(3): 326 doi: 10.1016/j.drudis.2013.11.020
|
| 34 |
Man Li, Hao Zheng, Qing-bao Tian, Mei-na Rui, Dian-wu Liu. HLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysis. Archives of Medical Research 2014; 45(3): 270 doi: 10.1016/j.arcmed.2014.03.002
|
| 35 |
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento. Gastroenterología y Hepatología 2011; 34(1): 41 doi: 10.1016/j.gastrohep.2010.02.006
|
| 36 |
Tanja Schoknecht, Dorothee Schwinge, Stephanie Stein, Christina Weiler-Normann, Marcial Sebode, Sören Mucha, Benjamin Otto, Eva Ellinghaus, Felix Stahl, Andre Franke, Ansgar W Lohse, Johannes Herkel, Christoph Schramm. CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. Journal of Leukocyte Biology 2017; 101(2): 589 doi: 10.1189/jlb.5A1015-469R
|
| 37 |
Floris J. M. Roos, Haoyu Wu, Jorke Willemse, Ruby Lieshout, Laura A. Muñoz Albarinos, Yik‐Yang Kan, Jan‐Werner Poley, Marco J. Bruno, Jeroen de Jonge, Richard Bártfai, Hendrik Marks, Jan N. M. IJzermans, Monique M. A. Verstegen, Luc J. W. van der Laan. Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro. Clinical and Translational Medicine 2021; 11(12) doi: 10.1002/ctm2.566
|
| 38 |
Alberto Quaglia. Practical Hepatic Pathology: A Diagnostic Approach. 2011; : 383 doi: 10.1016/B978-0-443-06803-4.00027-7
|
| 39 |
Francesca Saffioti, Kurinchi Selvan Gurusamy, Neil Hawkins, Clare D Toon, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn. Pharmacological interventions for primary sclerosing cholangitis. Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011343.pub2
|
| 40 |
Michael H. Trauner. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 475 doi: 10.1007/978-1-4419-7107-4_32
|
| 41 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
|
| 42 |
E. L. Culver, R. W. Chapman. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2011; 33(12): 1273 doi: 10.1111/j.1365-2036.2011.04658.x
|
| 43 |
Roger W. Chapman. Primary sclerosing cholangitis. Medicine 2011; 39(10): 588 doi: 10.1016/j.mpmed.2011.07.003
|
| 44 |
George F. Mells, Arthur Kaser, Tom H. Karlsen. Novel insights into autoimmune liver diseases provided by genome-wide association studies. Journal of Autoimmunity 2013; 46: 41 doi: 10.1016/j.jaut.2013.07.004
|
| 45 |
Leilei Yu, Yaru Liu, Shunhe Wang, Qingsong Zhang, Jianxin Zhao, Hao Zhang, Arjan Narbad, Fengwei Tian, Qixiao Zhai, Wei Chen. Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2181930
|
| 46 |
A.V. Nikitin, G.V. Volynets, T.A. Skvortsova, M.S. Kapranova. Extraintestinal manifestations of inflammatory bowel disease. Dokazatel'naya gastroenterologiya 2023; 12(1): 93 doi: 10.17116/dokgastro20231201193
|
| 47 |
Kurinchi Selvan Gurusamy, Francesca Saffioti, Clare D Toon, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews. 2014; doi: 10.1002/14651858.CD011343
|
| 48 |
Casey A. Rimland, Samantha G. Tilson, Carola M. Morell, Rute A. Tomaz, Wei‐Yu Lu, Simone E. Adams, Nikitas Georgakopoulos, Francisco Otaizo‐Carrasquero, Timothy G. Myers, John R. Ferdinand, Richard L. Gieseck, Fotios Sampaziotis, Olivia C. Tysoe, Alexander Ross, Judith M. Kraiczy, Brandon Wesley, Daniele Muraro, Matthias Zilbauer, Gabriel C. Oniscu, Nicholas R.F. Hannan, Stuart J. Forbes, Kourosh Saeb‐Parsy, Thomas A. Wynn, Ludovic Vallier. Regional Differences in Human Biliary Tissues and Corresponding In Vitro–Derived Organoids. Hepatology 2021; 73(1): 247 doi: 10.1002/hep.31252
|
| 49 |
Pietro Invernizzi. Primary sclerosing cholangitis is changing clinical spectrum and old biomarkers disclose an innovative role: The case of alkaline phosphatase. Digestive and Liver Disease 2011; 43(4): 268 doi: 10.1016/j.dld.2011.02.006
|
| 50 |
Marion J. Pollheimer, Michael Trauner, Peter Fickert. Will we ever model PSC? – “It's hard to be a PSC model!”. Clinics and Research in Hepatology and Gastroenterology 2011; 35(12): 792 doi: 10.1016/j.clinre.2011.04.014
|
| 51 |
Maria IS Achenza, Francesca Meda, Enrico Brunetta, Carlo Selmi. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. Expert Review of Gastroenterology & Hepatology 2012; 6(6): 717 doi: 10.1586/egh.12.58
|
| 52 |
Peter Fickert, Marion J. Pollheimer, Ulrich Beuers, Carolin Lackner, Gideon Hirschfield, Chantal Housset, Verena Keitel, Christoph Schramm, Hanns-Ulrich Marschall, Tom H. Karlsen, Espen Melum, Arthur Kaser, Bertus Eksteen, Mario Strazzabosco, Michael Manns, Michael Trauner. Characterization of animal models for primary sclerosing cholangitis (PSC). Journal of Hepatology 2014; 60(6): 1290 doi: 10.1016/j.jhep.2014.02.006
|
| 53 |
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
|
| 54 |
Andrea T. Borchers, Shinji Shimoda, Christopher Bowlus, Carl L. Keen, M. Eric Gershwin. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Seminars in Immunopathology 2009; 31(3): 309 doi: 10.1007/s00281-009-0167-2
|
| 55 |
Kerem Sebib Korkmaz, Bert‐Jan F. de Rooij, Bart van Hoek, Marcel Janse, Minneke J. Coenraad, Johan J. van der Reijden, Rinse K. Weersma, Robert J. Porte, Philip W. Voorneveld, Andrzej G. Baranski, Hein W. Verspaget. MMP‐2 is a disease‐modifying gene in primary sclerosing cholangitis. Liver International 2014; 34(2): 274 doi: 10.1111/liv.12237
|
| 56 |
Jonathan H. Aron, Christopher L. Bowlus. The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 2009; 31(3): 383 doi: 10.1007/s00281-009-0154-7
|
| 57 |
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatment. Orvosi Hetilap 2013; 154(24): 923 doi: 10.1556/OH.2013.29640
|
| 58 |
A. M. Arenas-Gamboa, J. J. Bearss, G. B. Hubbard, B. F. Porter, M. A. Owston, E. J. Dick Jr. Sclerosing Cholangitis in Baboons (Papio spp) Resembling Primary Sclerosing Cholangitis of Humans. Veterinary Pathology 2012; 49(3): 524 doi: 10.1177/0300985811419532
|
| 59 |
Dimitrios Bogdanos, Patrick S.C. Leung, M. Eric Gershwin. Mucosal Immunology. 2015; : 1695 doi: 10.1016/B978-0-12-415847-4.00087-2
|
| 60 |
Roger W. Chapman. Primary sclerosing cholangitis. Medicine 2015; 43(11): 648 doi: 10.1016/j.mpmed.2015.08.003
|
| 61 |
C. Buffet. Cholangites sclérosantes. EMC - Hépatologie 2011; 6(1): 1 doi: 10.1016/S1155-1976(11)50375-4
|
| 62 |
Corma MA Otte, Jan Rothuizen, Robert P Favier, Louis C Penning, Sandra Vreman. A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis. Journal of Feline Medicine and Surgery 2014; 16(10): 796 doi: 10.1177/1098612X14520811
|
| 63 |
|
| 64 |
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?. Digestive and Liver Disease 2010; 42(8): 529 doi: 10.1016/j.dld.2010.02.016
|
| 65 |
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Liver International 2019; 39(12): 2330 doi: 10.1111/liv.14183
|
| 66 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; : 52 doi: 10.1016/B978-1-4377-0765-6.10003-5
|
| 67 |
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, MohammedY Alghamdi, AbdullahS Alghamdi. Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation. Saudi Journal of Gastroenterology 2021; 27(7): 1 doi: 10.4103/sjg.sjg_112_21
|
| 68 |
Babunilayam Gangadharan, Bernadette M Dutia, Susan M Rhind, Anthony A Nash. Murid herpesvirus‐4 induces chronic inflammation of intrahepatic bile ducts in mice deficient in gamma‐interferon signalling. Hepatology Research 2009; 39(2): 187 doi: 10.1111/j.1872-034X.2008.00440.x
|
| 69 |
Emmanouil Sinakos, Keith Lindor. Treatment options for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2010; 4(4): 473 doi: 10.1586/egh.10.33
|
| 70 |
Seung Hee Woo, Sang-Hee Lee, Sung-Je Moon, Jeongsu Han, Kang-Sik Seo, Heedoo Lee, Chul-Ho Lee, Jung Hwan Hwang. Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models. Life Sciences 2024; 337: 122342 doi: 10.1016/j.lfs.2023.122342
|